ACS Symposium Series - Complete Accounts of Integrated Drug Discovery and Development: Recent Examples from the Pharmaceutical Industry Volume 1
Latest Publications

TOTAL DOCUMENTS

(FIVE YEARS 0)

H-INDEX

(FIVE YEARS 0)

Published By American Chemical Society

9780841233980, 9780841233966

Latest Documents Most Cited Documents Contributed Authors Related Sources Related Keywords

Editors’ Biographies

ACS Symposium Series - Complete Accounts of Integrated Drug Discovery and Development: Recent Examples from the Pharmaceutical Industry Volume 1 ◽

10.1021/bk-2018-1307.ot001 ◽

2018 ◽

pp. 287-288

Download Full-text

Discovery and Chemical Development of Verubecestat, a BACE1 Inhibitor for the Treatment of Alzheimer’s Disease

ACS Symposium Series - Complete Accounts of Integrated Drug Discovery and Development: Recent Examples from the Pharmaceutical Industry Volume 1 ◽

10.1021/bk-2018-1307.ch003 ◽

2018 ◽

pp. 53-89

Author(s):

David A. Thaisrivongs ◽

William J. Morris ◽

Jack D. Scott

Keyword(s):

Alzheimer’S Disease ◽

Alzheimer's Disease ◽

Bace1 Inhibitor

Download Full-text

Discovery and Chemical Development of JNJ-50138803, a Clinical Candidate BACE1 Inhibitor

ACS Symposium Series - Complete Accounts of Integrated Drug Discovery and Development: Recent Examples from the Pharmaceutical Industry Volume 1 ◽

10.1021/bk-2018-1307.ch004 ◽

2018 ◽

pp. 91-114

Author(s):

Harrie J. M. Gijsen ◽

Jinguang Lin ◽

Yannis Houpis

Keyword(s):

Bace1 Inhibitor ◽

Clinical Candidate

Download Full-text

Design and Development of the Glucokinase Activator AZD1656

ACS Symposium Series - Complete Accounts of Integrated Drug Discovery and Development: Recent Examples from the Pharmaceutical Industry Volume 1 ◽

10.1021/bk-2018-1307.ch007 ◽

2018 ◽

pp. 185-220

Author(s):

Darren McKerrecher ◽

Alan Steven

Keyword(s):

Design And Development ◽

Glucokinase Activator

Download Full-text

AZD6564, Discovery of a Potent 5-Substituted Isoxazol-3-ol Fibrinolysis Inhibitor and Development of an Enantioselective Large-Scale Route for Its Preparation

ACS Symposium Series - Complete Accounts of Integrated Drug Discovery and Development: Recent Examples from the Pharmaceutical Industry Volume 1 ◽

10.1021/bk-2018-1307.ch006 ◽

2018 ◽

pp. 151-184

Author(s):

Staffan Karlsson ◽

Daniel Pettersen ◽

Henrik Sörensen

Keyword(s):

Large Scale ◽

Fibrinolysis Inhibitor

Download Full-text

Discovery and Development of GDC-0994: A Selective and Efficacious Small Molecule Inhibitor of ERK1/2

ACS Symposium Series - Complete Accounts of Integrated Drug Discovery and Development: Recent Examples from the Pharmaceutical Industry Volume 1 ◽

10.1021/bk-2018-1307.ch001 ◽

2018 ◽

pp. 1-28 ◽

Cited By ~ 1

Author(s):

Xin Linghu ◽

Nicholas Wong ◽

James F. Blake ◽

John J. Gaudino ◽

John G. Moffat

Keyword(s):

Small Molecule ◽

Small Molecule Inhibitor ◽

Molecule Inhibitor

Download Full-text

Preclinical Identification and Development of AM-6138: An Inhibitor of BACE1 for the Treatment of Alzheimer’s Disease

ACS Symposium Series - Complete Accounts of Integrated Drug Discovery and Development: Recent Examples from the Pharmaceutical Industry Volume 1 ◽

10.1021/bk-2018-1307.ch002 ◽

2018 ◽

pp. 29-52 ◽

Cited By ~ 1

Author(s):

Steven M. Mennen ◽

John Stellwagen ◽

Ryan D. White

Keyword(s):

Alzheimer’S Disease ◽

Alzheimer's Disease

Download Full-text

Title, Copyright, Foreword

ACS Symposium Series - Complete Accounts of Integrated Drug Discovery and Development: Recent Examples from the Pharmaceutical Industry Volume 1 ◽

10.1021/bk-2018-1307.fw001 ◽

2018 ◽

pp. i-v

Download Full-text

Foreword

ACS Symposium Series - Complete Accounts of Integrated Drug Discovery and Development: Recent Examples from the Pharmaceutical Industry Volume 1 ◽

10.1021/bk-2018-1307.pr001 ◽

2018 ◽

pp. ix-x

Download Full-text

Subject Index

ACS Symposium Series - Complete Accounts of Integrated Drug Discovery and Development: Recent Examples from the Pharmaceutical Industry Volume 1 ◽

10.1021/bk-2018-1307.ix002 ◽

2018 ◽

pp. 293-298

Download Full-text

ACS Symposium Series - Complete Accounts of Integrated Drug Discovery and Development: Recent Examples from the Pharmaceutical Industry Volume 1Latest Publications

TOTAL DOCUMENTS

H-INDEX

Published By American Chemical Society

Editors’ Biographies

Discovery and Chemical Development of Verubecestat, a BACE1 Inhibitor for the Treatment of Alzheimer’s Disease

Discovery and Chemical Development of JNJ-50138803, a Clinical Candidate BACE1 Inhibitor

Design and Development of the Glucokinase Activator AZD1656

AZD6564, Discovery of a Potent 5-Substituted Isoxazol-3-ol Fibrinolysis Inhibitor and Development of an Enantioselective Large-Scale Route for Its Preparation

Discovery and Development of GDC-0994: A Selective and Efficacious Small Molecule Inhibitor of ERK1/2

Preclinical Identification and Development of AM-6138: An Inhibitor of BACE1 for the Treatment of Alzheimer’s Disease

Title, Copyright, Foreword

Foreword

Subject Index

ACS Symposium Series - Complete Accounts of Integrated Drug Discovery and Development: Recent Examples from the Pharmaceutical Industry Volume 1
Latest Publications